Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
Young Joseph R has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Young Joseph R is listed as SVP, FINANCE, CHIEF ACCT OFFCR at Vera Therapeutics, Inc. Inside the rolling window, Young Joseph R reported no open-market purchases and 2 open-market sales totaling $567K in VERA. The largest disclosed transaction in the window is a sale of 15,000 VERA shares on Nov 11, 2025, worth $436K.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$567K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Young Joseph R made?
Young Joseph R has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Young Joseph R trade?
Young Joseph R has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Young Joseph R's most recent SEC Form 4 filing?
Young Joseph R's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Young Joseph R's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Young Joseph R is listed as SVP, FINANCE, CHIEF ACCT OFFCR.
What is Young Joseph R's total buy and sell value in the current window?
Inside the rolling retention window, Young Joseph R bought $0 and sold $567K based on SEC Form 4 filings.
What was Young Joseph R's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 VERA shares on 2025-11-11, worth $436K, per SEC Form 4 filings.